Xuetongsu attenuates bone destruction in rheumatoid arthritis by suppressing RANKL/RANK/NFATc1 pathway to inhibit osteoclastogenesis and bone resorption

These findings indicate that Xuetongsu has been demonstrated to inhibit bone destruction by targeting the RANKL/RANK/NFATc1 pathway and could serve as a potential therapeutic agent for RA-associated bone destruction.